Exactech Strengthens Position as Soft Tissue Balancing Technology Leader with New Patents
The two newly granted patents build on a previously awarded patent by broadening the scope of position and orientation of the mechanical actuators in the company's Newton soft tissue balancing device. Additionally, these patents encompass a broader range of function including singular distraction elements that can maintain constant force through a wide range of motion, enabling increased capability and protection for future evolution of Exactech's Newton portfolio.
"Exactech is committed to leading the industry with innovative soft tissue management technologies that address the growing need for improved patient satisfaction and outcomes in knee replacement," said
Powered by Active Intelligence®, the Newton Knee technique works in concert with ExactechGPS® to provide orthopaedic surgeons with dynamic soft tissue analytics, pre-resection operative insights and full-range personalized planning designed to simplify, evaluate and execute balanced total knee replacement surgery.
For more information, visit www.NewtonKnee.com.
About Exactech
Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/exactech-strengthens-position-as-soft-tissue-balancing-technology-leader-with-new-patents-302123292.html
SOURCE Exactech, Inc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yum China to Report Second Quarter 2026 Financial Results
- As Stress, Burnout, and Digital Overload Shape Daily Life, "Doing Nothing" Can Help the Body and Mind Recover
- TransportBPO Sets the Standard Among Top Taxi Answering Service and Dispatch Outsourcing Providers
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share